Pancreatic Cystic Neoplasms: Update and International Harmonization of the 2018 European Evidence-Based Guidelines on Pancreatic Cystic Neoplasms - EPC
Brief description of the initiative: The aim is to harmonize the existing 5-year-old EPC/UEG "European evidence-based guidelines on pancreatic cystic neoplasms” into global, evidence-based guidelines for the management of pancreatic cystic tumours. These guidelines should result in less variation in clinical practice and improved patient outcomes.
Project type: Guideline development
Participating UEG Member Societies: German Pancreas Club
Lead Coordinator:
Management of Disorders of DGBI: UEG European Guideline on Management of Disorders of Gut-Brain Interaction (DGBI) in Primary Care - ESPCG
Brief description of the initiative: The guidelines will cover the topics of:
- Diagnostic Criteria to consider DGBI in primary care (upper and lower GI tract). A specific reference to the positive diagnostic criteria (Rome IV) for primary care physicians
- Diagnostic probabilities based on the co-morbidities; they will facilitate the decision making to consider possible or not DGBI in primary care from patient history and longitudinal care.
- Positive diagnostic criteria (Rome IV) for primary care physicians
- Referral criteria to GI specialists and follow-up/shared-care between healthcare levels
- Quality of life (QoL) indicators/issues from the patient’s perspective (PROMs)
- Management strategies with a holistic approach.
- Biopsychosocial perspective and different levels of intervention: role of psychological support in primary care.
The scope of each topic and PICO questions to cover the topics will be defined by the steering group and approved in an in person working group meeting.
Project type: Guideline development
Participating UEG Member Societies: ESNM
Lead Coordinator:
Pain management in Acute Pancreatitis: European guidelines on Rational Prophylactic Use of Proton Pump Inhibitors – EPC
Brief description of the initiative: Acute pancreatitis (AP) is on the rise in Europe, with an incidence of 4.6 to 100 per 100,000. Pain is a key diagnostic feature, but its management lacks clear guidance. Recent meta-analysis found that existing guidelines have limited impact on pain management in AP, and no specific European guidelines are available. Previous guidelines from various organizations offer no recommendations on analgesic practices, and there's a notable absence of guidance for pediatric cases. Consequently, pain management in AP is often derived from general abdominal emergency protocols, using the WHO analgesic ladder, which has limitations for AP.
Project type: Guideline development
Participating UEG Member Societies: EPC, EDS, ESDO, ESPCG, EAGEN, EASGAR, ESPGHAN
Lead Coordinator:
Proton Pump Inhibitors: European guidelines on Rational Prophylactic Use of Proton Pump Inhibitors - LGD
Brief description of the initiative: Proton Pump Inhibitors (PPIs) are widely prescribed globally, with 20-40% of Europeans using them for acid-related gastrointestinal issues. Concerns have arisen due to potential adverse effects, such as small intestinal bacterial overgrowth and Clostridioides difficile infection. Existing guidelines lack consistency, contributing to up to 20% of PPI prescriptions being deemed inappropriate. A unified guideline is crucial to streamline management, offer evidence-based recommendations, and enhance patient outcomes and healthcare efficiency in Europe.
Project type: Guideline development
Participating UEG Member Societies: TSG, CSG, SPG, EHMSG.MFE, IGA,EAGEN, ESNM
Lead Coordinator: